Navigation Links
Winnick Family Clinical Research Center Celebrates 6th Anniversary
Date:3/3/2008

emphasis to patient-oriented research. We are confident that this is the cutting-edge of clinical research. Our hopes have been amply rewarded by the Center's groundbreaking research into some of the afflictions that are among the greatest scourges of our society. It's wonderful to see young, gifted scientists taking up the torch of pioneering research in the Human Genome era, and we can't wait to see what the 2008 Winnick Clinical Scholars and larger body of researchers at the Winnick Family Clinical Research Center will be working on over the coming year."

The Winnick Family Clinical Research Center is a fully staffed center for clinical research active in all major clinical departments, utilizing administration, nursing, and nutritional support, along with core laboratory services in sample processing, tissue culture, genome screening and bioinformatics.


'/>"/>
SOURCE Winnick Family Clinical Research Center
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. IsoTis Receives FDA Clearance for Accell Family of Products
2. Cardica and Cook Sign Agreement to Expand Cook Vascular Closure Device Product Family
3. Melanoma Research Foundation and Seattle Cancer Care Alliance Host Educational Symposium and Reception for Melanoma Patients, Family Members and Healthcare Providers
4. Chindexs United Family Hospitals and Clinics and NBC Enter into Healthcare Services Agreement
5. Dr. Charles A. Sims of California Cryobanks Family Cord Blood Services Named to National Stem Cell Advisory Council
6. Vaccines are Likely to Cause Insulin Dependent Diabetes in Over 2% of Children With a Strong Family History of Insulin Dependent Diabetes, New Data Indicates
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
9. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
10. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
11. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):ESHRE announces its campus workshop: 'Artificial Insemination: An Update' 2Old hay and Alpine ibex horns reveal how grasslands respond to climate change 2Old hay and Alpine ibex horns reveal how grasslands respond to climate change 3Scripps Research team uncovers chemical basis for extra 'quality control' in protein production 2Scripps Research team uncovers chemical basis for extra 'quality control' in protein production 3Scripps Research team uncovers chemical basis for extra 'quality control' in protein production 4Sangamo BioSciences Announces Presentation of Top Line Statistically Significant Phase 2 Data in Diabetic Neuropathy at Society for Neuroscience Meeti 59843 1Sangamo BioSciences Announces Presentation of Top Line Statistically Significant Phase 2 Data in Diabetic Neuropathy at Society for Neuroscience Meeti 59843 2Sangamo BioSciences Announces Presentation of Top Line Statistically Significant Phase 2 Data in Diabetic Neuropathy at Society for Neuroscience Meeti 59843 3Sangamo BioSciences Announces Presentation of Top Line Statistically Significant Phase 2 Data in Diabetic Neuropathy at Society for Neuroscience Meeti 59843 4Sangamo BioSciences Announces Presentation of Top Line Statistically Significant Phase 2 Data in Diabetic Neuropathy at Society for Neuroscience Meeti 59843 5Sangamo BioSciences Announces Presentation of Top Line Statistically Significant Phase 2 Data in Diabetic Neuropathy at Society for Neuroscience Meeti 59843 6Sangamo BioSciences Announces Presentation of Top Line Statistically Significant Phase 2 Data in Diabetic Neuropathy at Society for Neuroscience Meeti 59843 7Sangamo BioSciences Announces Presentation of Top Line Statistically Significant Phase 2 Data in Diabetic Neuropathy at Society for Neuroscience Meeti 59843 8Red Cross Strives to Help Disasters Vulnerable Population 59839 1Red Cross Strives to Help Disasters Vulnerable Population 59839 2Red Cross Strives to Help Disasters Vulnerable Population 59839 340 Years on the Leading Edge 3A Case Western Reserve Universitys Biomedical Engineering Department Commemorates Achievement Looks to Future 14546 140 Years on the Leading Edge 3A Case Western Reserve Universitys Biomedical Engineering Department Commemorates Achievement Looks to Future 14546 2